JP2006219454A5 - - Google Patents

Download PDF

Info

Publication number
JP2006219454A5
JP2006219454A5 JP2005036235A JP2005036235A JP2006219454A5 JP 2006219454 A5 JP2006219454 A5 JP 2006219454A5 JP 2005036235 A JP2005036235 A JP 2005036235A JP 2005036235 A JP2005036235 A JP 2005036235A JP 2006219454 A5 JP2006219454 A5 JP 2006219454A5
Authority
JP
Japan
Prior art keywords
agent according
therapeutic
prophylactic agent
dgla
skin disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005036235A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006219454A (ja
JP5546087B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP2005036235A external-priority patent/JP5546087B2/ja
Priority to JP2005036235A priority Critical patent/JP5546087B2/ja
Priority to EP19183855.6A priority patent/EP3581178B1/en
Priority to EP06713928.7A priority patent/EP1852114B1/en
Priority to PCT/JP2006/302787 priority patent/WO2006085687A1/ja
Priority to CA2599112A priority patent/CA2599112C/en
Priority to US11/884,199 priority patent/US9006287B2/en
Priority to CN 200610003112 priority patent/CN101019853B/zh
Priority to CN2012100164426A priority patent/CN102600174A/zh
Publication of JP2006219454A publication Critical patent/JP2006219454A/ja
Publication of JP2006219454A5 publication Critical patent/JP2006219454A5/ja
Publication of JP5546087B2 publication Critical patent/JP5546087B2/ja
Application granted granted Critical
Priority to US14/644,231 priority patent/US9943495B2/en
Priority to US15/911,806 priority patent/US10342773B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2005036235A 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤 Expired - Fee Related JP5546087B2 (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2005036235A JP5546087B2 (ja) 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤
EP19183855.6A EP3581178B1 (en) 2005-02-14 2006-02-10 Composition containing dihomo-(gamma)-linolenic acid (dgla) as active ingredient
EP06713928.7A EP1852114B1 (en) 2005-02-14 2006-02-10 Composition containing dihomo-y-linolenic acid (dgla) as active ingredient
PCT/JP2006/302787 WO2006085687A1 (ja) 2005-02-14 2006-02-10 ジホモ−γ−リノレン酸(DGLA)を有効成分として含んで成る組成物
CA2599112A CA2599112C (en) 2005-02-14 2006-02-10 Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
US11/884,199 US9006287B2 (en) 2005-02-14 2006-02-10 Composition comprising dihomo-γ-linolenic acid (DGLA) as active ingredient
CN 200610003112 CN101019853B (zh) 2005-02-14 2006-02-14 含有有效成分二均-γ-亚麻酸(DGLA)的组成物
CN2012100164426A CN102600174A (zh) 2005-02-14 2006-02-14 含有有效成分二均-γ-亚麻酸(DGLA)的组成物
US14/644,231 US9943495B2 (en) 2005-02-14 2015-03-11 Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient
US15/911,806 US10342773B2 (en) 2005-02-14 2018-03-05 Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005036235A JP5546087B2 (ja) 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012013311A Division JP2012082226A (ja) 2012-01-25 2012-01-25 皮膚疾患経口治療または予防剤

Publications (3)

Publication Number Publication Date
JP2006219454A JP2006219454A (ja) 2006-08-24
JP2006219454A5 true JP2006219454A5 (https=) 2008-03-27
JP5546087B2 JP5546087B2 (ja) 2014-07-09

Family

ID=36981996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005036235A Expired - Fee Related JP5546087B2 (ja) 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤

Country Status (2)

Country Link
JP (1) JP5546087B2 (https=)
CN (1) CN101019853B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006306812A (ja) * 2005-04-28 2006-11-09 Suntory Ltd 好酸球浸潤抑制剤
JP2006306813A (ja) * 2005-04-28 2006-11-09 Suntory Ltd 肥満細胞増殖抑制剤
WO2006085687A1 (ja) 2005-02-14 2006-08-17 Suntory Limited ジホモ−γ−リノレン酸(DGLA)を有効成分として含んで成る組成物
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
WO2012153832A1 (ja) 2011-05-12 2012-11-15 日本水産株式会社 炎症性疾患用皮膚外用組成物
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US9855236B2 (en) 2011-10-19 2018-01-02 Ds Biopharma Limited Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof
SG11201401629XA (en) * 2011-10-19 2014-05-29 Dignity Sciences Ltd Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
PL3077489T3 (pl) 2013-12-04 2021-11-08 Nippon Suisan Kaisha, Ltd. Olej drobnoustrojowy zawierający kwas dihomo-gamma-linolenowy i biomasa drobnoustrojowa zawierająca kwas dihomo-gamma-linolenowy
ES2784240T3 (es) 2014-06-04 2020-09-23 Ds Biopharma Ltd Composiciones farmacéuticas que comprenden DGLA y uso de las mismas
EP3399971A1 (en) * 2016-01-07 2018-11-14 DS Biopharma Limited Pharmaceutical compositions comprising dgla and use of same
BR112018073060A2 (pt) * 2016-06-01 2019-04-09 Nestec S.A. composição para uso na profilaxia de doença alérgica
EP3624787A1 (en) * 2017-05-19 2020-03-25 DS Biopharma Limited Pharmaceutical compositions comprising dgla and use of same
AU2019417798B2 (en) * 2018-12-28 2025-08-14 Nippon Suisan Kaisha, Ltd. Dihomo-γ-linolenic acid-containing microbial oil with reduced arachidonic acid content
CN114585355A (zh) * 2019-10-01 2022-06-03 三得利控股株式会社 借由水通道蛋白3的表达调节的肠功能改善用组合物及其应用
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases
US20240398747A1 (en) * 2021-10-13 2024-12-05 Kao Corporation Anti-allergic agent
EP4417200A4 (en) * 2021-10-13 2025-10-15 Kao Corp AGENT FOR THE PREVENTION, TREATMENT OR ALLEVIATION OF INFLAMMATORY SKIN DISEASE
WO2023181755A1 (ja) * 2022-03-22 2023-09-28 東洋紡株式会社 皮膚機能関連因子に関する遺伝子の発現調節剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47777B1 (en) * 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
GB8806737D0 (en) * 1988-03-22 1988-04-20 Efamol Holdings Therapeutic composition & method
JP2002047176A (ja) * 2000-08-04 2002-02-12 Idemitsu Technofine Co Ltd IgE産生抑制剤

Similar Documents

Publication Publication Date Title
JP2006219454A5 (https=)
CA2549103C (en) Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
ES2369074T3 (es) Composiciones que tienen efectos preventivos o mejoradores de síntomas o enfermedades provocados por una hipofunción cerebral.
HU226673B1 (en) Use of essential fatty acids and bioactive disulphides for the preparation of therapeutic and dietary compositions
JP2007523049A5 (https=)
JP2021508321A (ja) 睡眠及び気分障害の治療及び/又は改善における使用のための組成物
US9687462B2 (en) Sn-2-monoacylglycerols and lipid malabsorption
WO2009091538A8 (en) Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia
NZ600740A (en) Compositions containing pufa and/or uridine and methods of use thereof
JP2008505177A5 (https=)
RU2771277C2 (ru) Лечение травматического повреждения головного мозга
CN110730659A (zh) 用于提高l-dopa治疗功效的组合物
JP2006306812A5 (https=)
KR20190050016A (ko) 오메가-3을 유효성분으로 포함하는 안구 건조증의 예방 또는 개선용 건강 기능성 식품조성물
US20160263072A1 (en) Monoacylglycerols and fat-soluble nutrients for use in the treatment of malabsorption having a non-mechanical basis
JP2007326799A5 (https=)
JP5759663B2 (ja) 皮膚バリア機能改善剤等
JP2012077022A (ja) Il−8発現抑制組成物
JP4852296B2 (ja) 血管炎症候群予防・治療剤
CA2427289A1 (en) Fat composition and hexacosanoic acid depressant for oral or enteral administration
RU99106551A (ru) Применение арахидоновой кислоты и/или докозагексаеновой кислоты для получения лекарства для лечения диспраксии
JP2007230912A (ja) 神経再生促進剤、および該促進剤を含む機能性食品
JP2006254885A (ja) 花粉症を改善及び予防する飲食物
TH138990A (th) ผลกระทบทางเมตาบอลิคของลิปิดที่ได้รับการจัดโครงสร้าง
MXPA00000793A (en) Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides